A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Trial details
- Registry ID
- NCT07188558
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Yescarta; axi-cel
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyNCT07188558 | LYEL | Phase 3 | Recruiting | 2029-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |